NEXT STEPS

From aligning your IT with your business needs to an end-to-end strategy for transforming your enterprise, TCS has the world-class experience and expertise that you need. Contact a consultant today.

Email TCS:

Find a TCS Location:

Brochure

R&D IT Transformation

 

Despite spending more time and money on R&D, organizations are still producing fewer quality drugs than before because of factors like rising costs, decline in the new drug pipeline and stringent regulatory compliance norms, which have affected the long-term business viability.

TCS’ R&D IT Transformation offering helps you rationalize and optimize your portfolio of applications and facilitates effective collaboration between various stakeholders. Consequently, in the drug development business area, you can target selective areas for improvement such as the following and leverage emerging technologies like mobility, social media and cloud:

  • Metadata-driven Clinical Data Management (CDM)
  • Clinical Data Repository (CDR) and analytics
  • Master Data Management (MDM)
  • Collaboration portal
  • eTMF
  • Modular authoring
  • SOA-based integration

The TCS Advantage

To support all R&D IT transformation initiatives, we have created a Pharmaceutical Industry Reference Architecture (PIRA), which provides business, information and application architecture views along with reference architectures for select solution areas

Benefits

  • End-to-end advisory, implementation and support services
  • A reference architecture-driven approach to R&D optimization
  • Use of architecture and technology components to realize the future state of the R&D IT landscape